Treprostinil is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Alembic Pharmaceuticals Inc.. The primary component is Treprostinil.
Product ID | 62332-515_640d13cf-e774-4d34-8c81-3410f9724130 |
NDC | 62332-515 |
Product Type | Human Prescription Drug |
Proprietary Name | Treprostinil |
Generic Name | Treprostinil |
Dosage Form | Injection, Solution |
Route of Administration | INTRAVENOUS; SUBCUTANEOUS |
Marketing Start Date | 2021-02-11 |
Marketing Category | ANDA / ANDA |
Application Number | ANDA211574 |
Labeler Name | Alembic Pharmaceuticals Inc. |
Substance Name | TREPROSTINIL |
Active Ingredient Strength | 50 mg/20mL |
Pharm Classes | Prostacycline Vasodilator [EPC],Prostaglandins I [CS],Vasodilation [PE] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2021-02-11 |
NDC Exclude Flag | N |
Sample Package? | N |
NDC | Brand Name | Generic Name |
---|---|---|
0703-0666 | Treprostinil | Treprostinil |
0703-0676 | Treprostinil | Treprostinil |
0703-0686 | Treprostinil | Treprostinil |
0703-0696 | Treprostinil | Treprostinil |
0781-3420 | Treprostinil | treprostinil |
0781-3425 | Treprostinil | treprostinil |
0781-3427 | Treprostinil | treprostinil |
0781-3430 | Treprostinil | treprostinil |
42023-206 | Treprostinil | Treprostinil |
42023-207 | Treprostinil | Treprostinil |
42023-208 | Treprostinil | Treprostinil |
42023-209 | Treprostinil | Treprostinil |
62332-514 | Treprostinil | Treprostinil |
62332-515 | Treprostinil | Treprostinil |
62332-516 | Treprostinil | Treprostinil |
62332-517 | Treprostinil | Treprostinil |
66302-300 | Orenitram | treprostinil |
66302-101 | Remodulin | treprostinil |
66302-102 | Remodulin | treprostinil |
66302-105 | Remodulin | treprostinil |
66302-110 | Remodulin | treprostinil |
66302-206 | TYVASO | treprostinil |